Trending News
News
News
Galapagos and Cystic Fibrosis Foundation Therapeutics Announce New Drug Discovery Collaboration
Collaboration aims to identify small molecules derived from natural sources that improve the function of a defective protein found in people who have cystic fibrosis.
News
Abraxis Signs Agreement with Green Cross Corporation for the Commercialization of ABRAXANE in Korea
Green Cross is responsible for the commercialization of ABRAXANE in Korea and will employ an exclusive sales force following regulatory and pricing approval for ABRAXANE.
News
ImmunoVaccine Technologies Completes Scale-Up of VacciMax® to Commercially Relevant Scale
The work validates the suitability of the platform for commercial applications in therapeutic cancer and infectious disease indications.
News
Vermillion Announces Issuance of U.S. Patent Covering Method for Aiding Diagnosis of Kidney Disorder
The U.S. Patent office has issued Vermillion U.S. Patent No. 7,297,556 for aiding diagnosis of nephrotic syndrome.
News
Genedata Provides Expressionist Platform to U.S. Food and Drug Administration
Genedata Expressionist is a computational platform for biomarker discovery that integrates transcriptomics, proteomics and metabolomics data within a single enterprise software system.
News
Thermo Fisher Scientific to Implement Darwin LIMS at APP Pharmaceuticals
Multi-site pharmaceutical manufacturing operation standardizes on Thermo Scientific solution.
News
Pharmacopeia and GlaxoSmithKline Collaboration Identifies two Additional Lead Compounds
The first of the lead compounds forms the basis to develop a treatment for respiratory disease and the other for inflammatory pain.
News
CytRx Reports Favorable Safety and Tolerability Results from High Dose, 28-Day Clinical Trial with Arimoclomol
Results support four-fold higher arimoclomol dose for planned Phase IIb efficacy trial for ALS.
News
ImmunoCellular Therapeutics Agrees to Acquire Molecular Antibody Technology
ImmunoCellular has entered into an agreement with Molecular Discoveries covering the IMUC’s acquisition of all monoclonal antibody related technology owned by MDC.
News
Profiling of Tumor Tissue Slices is Awarded Prize
Novel drug screening tool based on the Bionas® 2500 analyzing system wins silver medal in European business plan contest.
Advertisement